1-20 of 92
Tatyana Feldman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The genetic landscape of lymphoma: Insights from a primary immunodeficiency NGS panel in lymphoma patients

Free
Vanisha Patel, Lindsay Fogel, Nicole Araujo, Andrew Ip, Tatyana Feldman
Journal: Blood
Blood (2025) 146 (Supplement 1): 7069.
https://doi.org/10.1182/blood-2025-7069
Published: 2025
Journal Articles

Liquid-biopsy mutation landscape and its concordance with skin biopsies in cutaneous T-cell lymphoma

Free
Yoni Sacknovitz, Maher Albitar, Sara Suhl, Alexander Kaminsky, Brigit Lapolla, Joshua Kent, Maggie Zhou, Seda Tolu, Alejandro Gru, Barbara Pro, Tatyana Feldman, Larisa Geskin
Journal: Blood
Blood (2025) 146 (Supplement 1): 561.
https://doi.org/10.1182/blood-2025-561
Published: 2025
Journal Articles

A real-world analysis of safety and outcomes with first line nivolumab in combination with doxorubicin, vinblastine, and dacarbazine (NAVD) in patients with classic Hodgkin lymphoma (cHL) – a multicenter cohort study

Free
Allison Bock, Efrat Luttwak, Elena Nazarenko, Yizhe Xu, Swetha Thiruvengadam, Dahlia Sano, Kanithra Sekaran, John Vaughn, Daniel Reef, John Sharp, Ajay Major, Vrutti Patel, Nicole Araujo, Ritwick Mynam, Gordon Smilnak, Marisa Palmeri, Anuja Abhyankar, Drew Gerber, Ayo Falade, Praveen Ramakrishnan Geethakumari, Madiha Iqbal, Grace Baek, Mengyang Di, Boyu Hu, Urshila Durani, Hua-Jay Cherng, Alex Niu, Joanna Rhodes, Krithika Shanmugasundaram, Priyanka Pophali, Tatyana Feldman, Jakub Svoboda, Timothy Voorhees, Natalie Grover, Catherine Diefenbach, Reem Karmali, Yasmin Karimi, Alex Herrera, Pallawi Torka, Narendranath Epperla
Journal: Blood
Blood (2025) 146 (Supplement 1): 1841.
https://doi.org/10.1182/blood-2025-1841
Published: 2025
Journal Articles

Sustained remissions beyond 4 years with epcoritamab monotherapy: Long term follow-up results from the pivotal EPCORE NHL-1 trial in patients with relapsed or refractory large B-cell lymphoma

Free
Yasmin Karimi, Chan Cheah, Julie Vose, Michael Roost Clausen, David Cunningham, Umar Farooq, Tatyana Feldman, Herve Ghesquieres, Wojciech Jurczak, Kim Linton, Tycel Phillips, Won Seog Kim, Pegah Jafarinasabian, Barbara D'Angelo MÃ¥nsson, Milan Geybels, Christian Eskelund, Martin Hutchings, Catherine Thieblemont
Journal: Blood
Blood (2025) 146 (Supplement 1): 5513.
https://doi.org/10.1182/blood-2025-5513
Published: 2025
Journal Articles

Impact of DUSP22 and TP63 rearrangements in patients with ALK-negative ALCL treated with frontline BV-CH(E)P

Free
Zachary Epstein-Peterson, Nivetha Ganesan, Christina Poh, Ranjana Advani, Umut Aypar, Bryce Bowler, Ellie Casper, Tiffany Chang, Ahmet Dogan, Ozgur Can Eren, Tatyana Feldman, Natasha Galasso, Vaishali Gautam, Paola Ghione, Sarvarinder Gill, Kelly Hannigan, Jonathan Isenberg, Swami Iyer, Katie Ksanznak, Andrew Lytle, Jonathan Moreira, Alison Moskowitz, Ranjit Nair, Timothy Oh, Evelyn Orlando, Jia Ruan, Kerry Savage, Graham Slack, Robert Stuver, Jessie Xu, Austin Yeung, Jasmine Zain, Yanming Zhang, Steven Horwitz
Journal: Blood
Blood (2025) 146 (Supplement 1): 5410.
https://doi.org/10.1182/blood-2025-5410
Published: 2025
Journal Articles

Intratumoral cellular immunotherapy with autologous hyperactivated M1 SIRPα-low macrophages in non-Hodgkin lymphoma: Clinical results from a first-in-human Phase 1 study

Free
Paolo Strati, Tatyana Feldman, Jelle Kylstra, Koby Kidder, Nathanael McCurley, Mehdi Al-Khalissi, Steven Ruck, Christiane Querfeld
Journal: Blood
Blood (2025) 146 (Supplement 1): 4148.
https://doi.org/10.1182/blood-2025-4148
Published: 2025
Journal Articles

Developing artificial intelligence-based transcriptomic signature for the diagnosis of dark zone lymphoma in patients without MYC gene rearrangement

Free
Andrew Ip, Maher Albitar, Hong Zhang, Sally Agersborg, Adam Albitar, Ahmad Charifa, Andrew Pecora, David Siegel, Lori Leslie, Andre Goy, Tatyana Feldman
Journal: Blood
Blood (2025) 146 (Supplement 1): 3525.
https://doi.org/10.1182/blood-2025-3525
Published: 2025
Journal Articles

Nivolumab with doxorubicin, vinblastine, and dacarbazine (NAVD) in older adults with classic Hodgkin lymphoma: Do S1826 results hold up in the real world?

Free
Pallawi Torka, Allison Bock, Elena Nazarenko, Yizhe Xu, John Vaughn, Swetha Thiruvengadam, Ajay Major, Kanithra Sekaran, Daniel Reef, Calvin Lee, Gordon Smilnak, Efrat Luttwak, Vrutti Patel, Harsh Shah, Andrew Ip, Grace Baek, Ritwick Mynam, Dahlia Sano, Drew Gerber, Ayo Falade, Marisa Palmeri, Rudy Mrad, Madiha Iqbal, John Sharp, Timothy Voorhees, Praveen Ramakrishnan Geethakumari, Joanna Rhodes, Urshila Durani, Hua-Jay Cherng, Yasmin Karimi, Priyanka Pophali, Mengyang Di, Tatyana Feldman, Jakub Svoboda, Krithika Shanmugasundaram, Alex Niu, Natalie Grover, Reem Karmali, Alex Herrera, Catherine Diefenbach, Narendranath Epperla
Journal: Blood
Blood (2025) 146 (Supplement 1): 3622.
https://doi.org/10.1182/blood-2025-3622
Published: 2025
Journal Articles

A multicenter real-world analysis of combined chemotherapy followed by consolidative radiation versus chemotherapy alone in the management of early-stage Hodgkin lymphoma – the HODGKIN25 study

Free
Nikita Dave, Alexandra Dreyfuss, Alison Moskowitz, Joachim Yahalom, Maria Alfaro, Nicole Birrer, Boyu Hu, Rachel Koch, Zachary Frosch, Meryl Colton, Carrie Ho, Behzad Amoozgar, Tatyana Feldman, Abhiraj Saxena, Joanna Rhodes, Ashley Dunton, Nirav Shah, Amelia Mantione, Harper Hubbeling, Michael Lariviere, John Plastaras, Stefan Barta, Jordan Carter, Elise Chong, Michael Cook, Daniel Landsburg, Sunita Dwivedy Nasta, Stephen Schuster, Colin Thomas, Emily Tomasulo, Jakub Svoboda
Journal: Blood
Blood (2025) 146 (Supplement 1): 3617.
https://doi.org/10.1182/blood-2025-3617
Published: 2025
Journal Articles

A Phase II multicenter study of minimal residual disease-guided, time-limited acalabrutinib + obinutuzumab for the initial treatment of chronic lymphocytic leukemia

Free
Meghan Thompson, Anthony Mato, Lia Palomba, Lori Leslie, Andriy Derkach, David Nemirovsky, Prioty Islam, Mark Geyer, Philip Caron, Aaron Goldberg, Anita Kumar, Alison Moskowitz, Jennifer Lue, Colette Owens, Gilles Salles, Eytan Stein, Raphael Steiner, Pallawi Torka, Lori Dahncke, Emily Ordona, Mashiyate Meem, Claire Hutzler, Miranda Harris, Monica Shah, Megha Karnam, Lauren Nogan, Caitlin Maloney, Anmol Shah, Tenzin Nyima, Colleen Dorsey, Kate Doyle, Jennifer Howgate-Klingaman, Jamila Brutus, Dianna Tyznar, Anna Lincke, Rick Wray, Tatyana Feldman, Andrew Zelenetz, Lindsey Roeker
Journal: Blood
Blood (2025) 146 (Supplement 1): 5676.
https://doi.org/10.1182/blood-2025-5676
Published: 2025
Journal Articles

Final results of a phase 1 trial with soquelitinib (SQL), a selective interleukin-2-inducible T cell kinase (ITK) inhibitor for treatment of relapsed/refractory (R/R) T cell lymphomas (TCL)

Free
Richard Miller, Ryan Wilcox, John Reneau, Costas Yannakou, Won Seog Kim, Tatyana Feldman, Youn-H Kim, Michael Khodadoust, Dejan Radeski, Robin Gasiorowski, Dok Hyun Yoon, Yuqin Song, Andrew Hotson, Suresh Mahabhashyam
Journal: Blood
Blood (2025) 146 (Supplement 1): 778.
https://doi.org/10.1182/blood-2025-778
Published: 2025
Journal Articles

Brentuximab Vedotin (BV) and Nivolumab (nivo) for Untreated Patients with Hodgkin Lymphoma (HL): Long-Term Results

Free
Bruce D. Cheson, Nancy L. Bartlett, Betsy R. LaPlant, Hun Ju Lee, Ranjana H. Advani, Beth Christian, Catherine S. Diefenbach, Tatyana Feldman, Stephen M. Ansell
Journal: Blood
Blood (2024) 144 (Supplement 1): 3045.
https://doi.org/10.1182/blood-2024-207424
Published: 2024
Journal Articles

Improving Outcomes in Plasmablastic Lymphoma: A Multicenter Experience from an American Cohort

Free
Matthew Hamby, Brian Egleston, Zachary AK Frosch, Raphael E. Steiner, Ariela Noy, Veronica Carvajal, Seda S. Tolu, Gaston Jean-Louis, Jennifer E. Amengual, Romil Patel, Sairah Ahmed, Timothy Voorhees, Robert Baiocchi, Andres Ramirez-Gamero, Jorge J. Castillo, Emily Hamburger, Christopher Dittus, Imran A. Nizamuddin, Neha Mehta-Shah, Nyein Nyein Thaw Dar, Jose Sandoval-Sus, Alexandra E. Rojek, Peter A. Riedell, Vinod Solipuram, Paul G. Rubinstein, Anthony Ariotti, Gita Suneja, Alexander Vartanov, Charles Milrod, Adam J. Olszewski, Gordon Smilnak, Emily Ayers, Sahaj Desai, Joanna M. Rhodes, Gabriella Magarelli, Tatyana Feldman, Meredith Pellon, David M. Aboulafia, William Bae, Carlos Galvez, Vineel Bhatlapenumarthi, Mehdi Hamadani, Stefan K. Barta
Journal: Blood
Blood (2024) 144 (Supplement 1): 573.
https://doi.org/10.1182/blood-2024-198008
Published: 2024
Journal Articles

Open-Label Phase 1 Study to Evaluate the Safety of SGN-35T in Patients with Relapsed/Refractory CD30-Expressing Lymphoid Malignancies (SGN35T-001; trial in progress)

Free
Tatyana Feldman, Hun Ju Lee, Gizelle Popradi, Graham P. Collins, Daniel Morillo, Ming Jin Yan, Tara Chen, Youn H. Kim
Journal: Blood
Blood (2024) 144 (Supplement 1): 6356.
https://doi.org/10.1182/blood-2024-200265
Published: 2024
Journal Articles

Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of KT-333, a Targeted Protein Degrader of STAT3, in Patients with Relapsed or Refractory Lymphomas, Leukemia, and Solid Tumors

Free
Tatyana Feldman, Enrica Marchi, Stephen D. Smith, Adam J. Olszewski, Auris O Huen, Zachary D. Epstein-Peterson, Don A. Stevens, Alexander N. Starodub, Eric J. Feldman, Cristina P Rodriguez, John C. Reneau, Jonathan E. Brammer, Ahmad H. Mattour, Lauren C. Pinter-Brown, Rachelle Perea, Patrick Henrick, Joyoti Dey, Alyssa Fasciano, Rahul Karnik, Sagar Agarwal, Ashwin Gollerkeri, Jared Gollob, Aditi Shastri, Stefan K. Barta
Journal: Blood
Blood (2024) 144 (Supplement 1): 4433.
https://doi.org/10.1182/blood-2024-210301
Published: 2024
Journal Articles

Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Updated Follow-up of Transcend CLL 004

Free
Tanya Siddiqi, Jordan Gauthier, Saad S. Kenderian, Danielle M. Brander, Kathleen Dorritie, Jacob D. Soumerai, Peter A. Riedell, Nirav N. Shah, Rajneesh Nath, Charalambos Andreadis, Daniel A. Ermann, Shuo Ma, Tatyana Feldman, Scott R. Solomon, Stephen J. Schuster, Sherilyn A. Tuazon, Serena K. Perna, San-San Ou, Neha Rane, Eniko Papp, Yizhe Chen, William G. Wierda
Journal: Blood
Blood (2024) 144 (Supplement 1): 4633.
https://doi.org/10.1182/blood-2024-200840
Published: 2024
Journal Articles

Lisocabtagene Maraleucel (liso-cel) Combined with Ibrutinib (ibr) for Patients (pts) with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): Primary Results from the Open-Label, Phase 1/2 Transcend CLL 004 Study

Free
William G. Wierda, Kathleen Dorritie, Jordan Gauthier, Rajneesh Nath, Thomas J. Kipps, Peter A. Riedell, Herbert A. Eradat, Saad S. Kenderian, Mohamed A. Kharfan-Dabaja, Nirav N. Shah, Scott R. Solomon, Daniel A. Ermann, Jon E. Arnason, Abhinav Deol, Tatyana Feldman, Charalambos Andreadis, Monalisa Ghosh, Shuo Ma, Stephen J. Schuster, Usama Gergis, Julie M. Vose, Jacob D. Soumerai, Koen van Besien, Sherilyn A. Tuazon, Serena K. Perna, San-San Ou, Neha Rane, Eniko Papp, Yizhe Chen, Tanya Siddiqi
Journal: Blood
Blood (2024) 144 (Supplement 1): 887.
https://doi.org/10.1182/blood-2024-200339
Published: 2024
Journal Articles

A Randomized Phase 2 Study Incorporating Nivolumab and Brentuximab Vedotin into Radiation-Free Treatment of Early Stage Classic Hodgkin Lymphoma

Free
Ann S. LaCasce, Deepa Jagadeesh, Hun Ju Lee, Lu Chen, David A. Bond, Matthew Weinstock, Matthew Mei, Tatyana Feldman, Allison M. Winter, Jeffrey A. Barnes, Amitkumar N. Mehta, Gaurav Goyal, Sairah Ahmed, Lisa Giulino Roth, Azra Borogovac, Kristie A. Blum, Jane N Winter, Mehdi Hamadani, Sonali M. Smith, Philippe Armand, Ian W. Flinn, Jeremy S. Abramson, Alex F. Herrera
Journal: Blood
Blood (2024) 144 (Supplement 1): 459.
https://doi.org/10.1182/blood-2024-204113
Published: 2024
Journal Articles

PET-Directed Therapy with ABVD Vs. Bv+AVD Followed By Nivolumab in Patients with Early Stage Hodgkin Lymphoma: A Propensity Score Matched Analysis of CALGB50604 and ACCRULY1601

Free
Steven I. Park, Stephen M. Ansell, Danielle Boselli, Sharmila Giri, Jakub Svoboda, Stephen D Smith, Tatyana Feldman, L. Elizabeth Budde, Andrew J Ness, Philip Bierman, Hun Ju Lee
Journal: Blood
Blood (2024) 144 (Supplement 1): 458.
https://doi.org/10.1182/blood-2024-202207
Published: 2024
Journal Articles

3-Year Update from the Epcore NHL-1 Trial: Epcoritamab Leads to Deep and Durable Responses in Relapsed or Refractory Large B-Cell Lymphoma

Free
Julie M. Vose, Chan Y. Cheah, Michael Roost Clausen, David Cunningham, Umar Farooq, Tatyana Feldman, Herve Ghesquieres, Wojciech Jurczak, Kim Linton, Catherine Thieblemont, Tycel J. Phillips, Won Seog Kim, Pegah Jafarinasabian, Barbara D'Angelo MÃ¥nsson, David Soong, Andrew J. Steele, Zhu Li, Christian Eskelund, Martin Hutchings, Yasmin H. Karimi
Journal: Blood
Blood (2024) 144 (Supplement 1): 4480.
https://doi.org/10.1182/blood-2024-198714
Published: 2024